Brief: Oncoarendi Therapeutics Appoints Samson Fung As Chief Medical Officer
27/01/2022 12:03
Jan 27 (Reuters) - Oncoarendi Therapeutics SA OAT.WA :
* SAYS SAMSON FUNG, M.D. AS CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nPrek3jP0a
Further company coverage: OAT.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments